Effects of EpCAM overexpression on human breast cancer cell lines
about
Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic deviceKnockdown of EpCAM enhances the chemosensitivity of breast cancer cells to 5-fluorouracil by downregulating the antiapoptotic factor Bcl-2Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevices.Characterization of microfluidic shear-dependent epithelial cell adhesion molecule immunocapture and enrichment of pancreatic cancer cells from blood cells with dielectrophoresis.Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients.Modelling circulating tumour cells for personalised survival prediction in metastatic breast cancerOptimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cellsFusion with stem cell makes the hepatocellular carcinoma cells similar to liver tumor-initiating cells.MMTV/LTR Promoter-Driven Transgenic Expression of EpCAM Leads to the Development of Large Pancreatic IsletsMetabolic stress induces a Wnt-dependent cancer stem cell-like state transition.MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.Bidirectional modulation of endogenous EpCAM expression to unravel its function in ovarian cancer.Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas.Role of the EpCAM (CD326) in prostate cancer metastasis and progression.Review: circulating tumor cells in the practice of breast cancer oncology.Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linkerEpithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.Photoresponsive immunomagnetic nanocarrier for capture and release of rare circulating tumor cells.Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology.Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC.Tumor necrosis factor-α-induced nuclear factor-kappaB activation in human cardiomyocytes is mediated by NADPH oxidase.A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA.Reversible re-programing of cell-cell interactions.Molecular Detection and Analysis of Exosomes Using Surface-Enhanced Raman Scattering Gold Nanorods and a Miniaturized Device.
P2860
Q28482878-64FECB52-22DB-4BB5-B263-0F6DCD33708FQ28540713-B578076F-21B8-4B57-98FE-91770AF30912Q30427356-23668510-866C-4ABD-B5F8-BFBEDDBF0647Q30978083-6DF8DE7B-96B8-4924-B2EB-19D1CC0AAB80Q33820631-706044A7-BC0B-4BCF-B02C-C562F80EB6CBQ34304356-B8FD709D-89AC-463F-AD68-E1F9BC7B311EQ34308781-B3FB1462-219B-4100-8E59-166969A6C664Q35610546-291A3A7B-AD46-4D42-9950-A50A6FED3456Q35626055-344498AA-2EA1-4D24-AF19-F4A7EFB35318Q35914875-5D83F4A8-8DF9-45E4-BB34-4E3FA2226692Q35932772-3F245131-AF50-4055-955D-59FA3F63DF04Q36293834-16364635-F1BA-4B39-967E-84F1E258B708Q36401886-F955BCA5-923B-4E8F-96D4-54CC5BB62F3DQ36663666-8E76C788-08F1-43D9-9CF7-5B769777121FQ37716015-E4D65B48-1D68-4BB8-B7F4-47E589FAEA51Q38020426-B7E1EE3E-B57F-499D-8EE8-02BA0C769546Q38662712-FF7EA5AD-9332-46BB-B9AD-A8A81AB25840Q38772382-6E2D9206-9A6C-422A-A167-146ADD73BF7EQ38958021-159CF222-9283-42DC-82B4-3B98F40E7738Q40993856-35DB1355-13DB-4822-8765-A92415FF0B36Q41566669-9234D37D-43F5-471A-8649-0E169E96058DQ41611344-F0C972F8-CF23-431E-A7B4-D52579B0A761Q46861646-9F5DE150-4530-4165-AADB-0C169BD251F2Q51075189-9EBD2FB1-C701-495B-87F1-6B9B592CE746Q51743858-79295841-2DDD-4A16-90E6-29A92F56D3A0Q54961725-7A5F416B-A986-4975-A9E0-98917EBFBFEE
P2860
Effects of EpCAM overexpression on human breast cancer cell lines
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effects of EpCAM overexpression on human breast cancer cell lines
@ast
Effects of EpCAM overexpression on human breast cancer cell lines
@en
type
label
Effects of EpCAM overexpression on human breast cancer cell lines
@ast
Effects of EpCAM overexpression on human breast cancer cell lines
@en
prefLabel
Effects of EpCAM overexpression on human breast cancer cell lines
@ast
Effects of EpCAM overexpression on human breast cancer cell lines
@en
P2093
P2860
P356
P1433
P1476
Effects of EpCAM overexpression on human breast cancer cell lines
@en
P2093
Agnieszka Martowicz
Dominic Fong
Florian Lehne
Gilbert Spizzo
Guenther Gastl
Johanna M Gostner
Marion Zitt
Martin Hermann
Oliver A Wrulich
Sylvia Krobitsch
P2860
P2888
P356
10.1186/1471-2407-11-45
P407
P577
2011-01-31T00:00:00Z
P5875
P6179
1037253518